Discussing individual goals and calorie targets with a healthcare provider helps set realistic and safe expectations
Specifically, future work should prioritize conducting specific animal studies to validate the hypothesized anti-fibrotic and anti-cancer effects of GLP-1 RAs in ALD and MetALD models
Retrieved on Sept 16, 2020 from Domingo, M
Bioorg Med Chem 94:117479
Sources Healthline: Who Can Prescribe Semaglutide
I tell all my patients I dont care about the number on the scale, its all about body composition, those secondary endpoints cardiometabolic parameters, and waist circumference, fat mass loss, visceral mass loss etc are whats important Thanks for sharing, Michael Thanks for sharing, Michael The SURMOUNT-5 trial's findings are remarkabletirzepatide (Zepbound) achieved a 20.2% average weight loss over 72 weeks, surpassing semaglutide's 13.7%